Bempedoic acid/Ezetimibe Prescribing at PROSPECT SURGERY
Lipid-regulating drugs | Cardiovascular System
Items (12m)
256
Total Quantity
3,948
NHS Cost
£7.4K
vs National Avg
+319.2%
PROSPECT SURGERY prescribed 256 items of Bempedoic acid/Ezetimibe over the last 12 months at a cost of £7,445 to the NHS. This is 319.2% above the national average prescribing rate. Bempedoic acid/Ezetimibe is classified under Lipid-regulating drugs in the BNF.
Monthly Prescribing Trend
Jun 2026
20
Jun 2026
16
Jun 2026
19
Jun 2026
22
Jun 2026
18
Jun 2026
23
Jun 2026
17
Jun 2026
19
Jun 2026
25
Jun 2026
28
Jun 2026
19
Jun 2026
30
Prescribing Details
| Total Items | 256 |
|---|---|
| Total Quantity | 3,948 |
| Total NHS Cost | £7,445 |
| Presentations | 2 different forms |
| vs National Average | +319.2% |
Bempedoic acid/Ezetimibe Prescribing Comparison
| This practice | 256 items |
|---|---|
| National average per practice | 61 items |
| Difference | +319.2% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.